ANG Lifesciences India Limited (BOM:540694)

ANG Lifesciences India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	4.94	1.57	3.19	3.24	3.46
Short-Term Investments	-	32.96	34.78	54.17	58.53	63.06
Cash & Short-Term Investments	37.89	37.89	36.36	57.35	61.78	66.52
Cash Growth	4.23%	4.23%	-36.61%	-7.16%	-7.14%	72.20%
Accounts Receivable	-	679.31	665.39	732.78	831.48	1,021
Other Receivables	-	11.71	9.91	8.08	15.19	10.82
Receivables	-	691.02	675.29	740.85	846.67	1,031
Inventory	-	462.61	541.09	477.66	484.87	369.59
Prepaid Expenses	-	1.1	1.47	2.09	3.43	3.04
Other Current Assets	-	300.91	399.19	511.41	451.78	457.61
Total Current Assets	-	1,494	1,653	1,789	1,849	1,928
Property, Plant & Equipment	-	506.13	571.93	583.97	881.48	926.14
Long-Term Investments	-	0.26	0.26	0.26	0.26	0.26
Long-Term Deferred Tax Assets	-	82.74	63.72	44.59	41.2	42.85
Other Long-Term Assets	-	6.83	6.64	6.19	5.16	12.93
Total Assets	-	2,089	2,296	2,424	2,777	2,910

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	525.09	660.74	661.79	681.86	706.29
Accrued Expenses	-	110.01	105.45	98.47	62.56	59.61
Short-Term Debt	-	649.41	558.83	503.25	449.29	465.84
Current Portion of Long-Term Debt	-	79.72	56.89	49.7	45.16	87.74
Current Portion of Leases	-	8.71	9.04	8.18	5.04	-
Current Income Taxes Payable	-	0.26	0.76	42.63	176.63	189.11
Current Unearned Revenue	-	42	12	10	-	-
Other Current Liabilities	-	75.17	30.66	71.64	202.31	154.3
Total Current Liabilities	-	1,490	1,434	1,446	1,623	1,663
Long-Term Debt	-	46.16	188.61	139.49	184.94	216.37
Long-Term Leases	-	9.99	18.7	27.73	23.06	-
Pension & Post-Retirement Benefits	-	13.13	12.76	11.44	10.61	14.95
Long-Term Deferred Tax Liabilities	-	-	-	13.34	14.91	6.15
Other Long-Term Liabilities	-	0.95	1.75	23.94	58.08	172.25
Total Liabilities	-	1,561	1,656	1,662	1,914	2,073

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	130.58	130.58	130.58	130.58	103.67
Additional Paid-In Capital	-	56.17	56.17	56.17	56.17	63.09
Retained Earnings	-	295.23	406.09	529.11	628.51	624.02
Comprehensive Income & Other	-	46.91	46.91	46.91	46.91	46.91
Shareholders' Equity	528.89	528.89	639.76	762.77	862.18	837.69
Total Liabilities & Equity	-	2,089	2,296	2,424	2,777	2,910

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	793.99	793.99	832.06	728.37	707.48	769.95
Net Cash (Debt)	-756.1	-756.1	-795.71	-671.01	-645.71	-703.43
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-58.01	-57.90	-60.93	-51.39	-49.70	-54.28
Filing Date Shares Outstanding	13.1	13.06	13.06	13.06	13.06	12.96
Total Common Shares Outstanding	13.1	13.06	13.06	13.06	13.06	12.96
Working Capital	-	3.17	219.03	343.7	225.69	265.23
Book Value Per Share	40.96	40.50	48.99	58.41	66.03	64.65
Tangible Book Value	528.89	528.89	639.76	762.77	862.18	837.69
Tangible Book Value Per Share	40.96	40.50	48.99	58.41	66.03	64.65
Land	-	60.1	60.1	57.78	148.57	153.43
Buildings	-	445.69	445.69	409.6	515.7	519.71
Machinery	-	698.02	710.32	693.16	774.45	746.59

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error